GlaxoSmithKline

Tamiflu is an amazingly effective drug, in terms of profit generation for the drug companies at least. Whether it’s of any significant use in containing the H1N1 swine flu pandemic is a matter of opinion.

Those who are making a pile of cash are convinced of the health benefits and, in the main, big media is happy to endorse the sales pitch. But Dr Tom Jefferson, of the Cochrane Collaboration in Rome, has a different view.
[click to continue…]

{ 2 comments }